Table 1

Baseline Characteristics of 32 Participants

Fluvastatin (n = 24)Control (n = 8)p Value
Age (yrs)63.4 ± 9.566.9 ± 4.00.33
Men19 (79%)7 (88%)0.99
Hypertension11 (46%)5 (63%)0.69
Hyperlipidemia4 (17%)1 (13%)0.99
Diabetes mellitus5 (21%)1 (13%)0.99
Obesity (BMI >25)3 (13%)0 (0%)0.55
Smoking4 (15%)3 (38%)0.33
Previous MI13 (50%)2 (25%)0.23
Time of follow-up (months)15.8 ± 8.414.0 ± 7.40.59
Lipid profile
 Total cholesterol (mg/dl)203.3 ± 31.1181.6 ± 33.50.12
 Triglyceride (mg/dl)158.6 ± 74.9181.4 ± 128.50.55
 HDL-C (mg/dl)53.2 ± 15.451.3 ± 12.90.77

BMI = body mass index; HDL-C = high-density lipoprotein cholesterol; MI = myocardial infarction.